Molecular testing with PCR and FISH enables accurate diagnosis of chromosomal translocations in sarcomas, highlighting potential future therapeutic targets.
Answers are grounded in this paper and cite their sources.
Supports molecular subtyping in sarcomas; leaves open whether targeted therapies improve outcomes.
Many sarcomas such as osteosarcoma have complex molecular compositions and behaviors that make standardized treatment difficult for patients with these tumors. Chromosomal translocations are noted in specific bone and soft-tissue sarcomas, and there are molecular tests (polymerase chain reaction [PCR] and fluorescence in situ hybridization [FISH]) used for accurate diagnosis. The translocations noted in sarcomas may allow future therapeutic targeting.
No takes yet. Share an insight, caveat, or question.
Wustrack et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: